Hospital
ST. Joseph Health System, LLC
ST. Joseph Health System, LLC was paid $25.43M by Medicaid between Jan 2018 and Dec 2024, across 135 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoST. JOSEPH HEALTH SYSTEM, LLC
FORT WAYNE, IN 46802
FORT WAYNE, IN 46802
33aNPI1023060472assigned 05/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.43M
24GClaims450,882
24DCodes billed135
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#16 of 69
Median peer was paid$9.76M
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,282 | $1.00M | |
| 2019 | 44,990 | $1.73M | |
| 2020 | 37,007 | $1.61M | |
| 2021 | 46,159 | $2.70M | |
| 2022 | 105,495 | $6.87M | |
| 2023 | 99,069 | $6.68M | |
| 2024incomplete | 62,880 | $4.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 46,226 | 38,790 | $7.79M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 34,364 | 27,231 | $5.85M |
| 71045 | Radiologic examination, chest; single view | 7.1% | 12,679 | 9,885 | $1.81M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.2% | 10,070 | 7,558 | $1.57M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5.6% | 21,576 | 15,249 | $1.42M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.0% | 11,212 | 8,952 | $769K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 5,988 | 5,196 | $704K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 2.6% | 266 | 236 | $655K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 923 | 670 | $391K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 12,860 | 10,628 | $366K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 2,321 | 1,746 | $282K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.1% | 2,648 | 2,000 | $269K |
123 more codes
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 538 | $225K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13,065 | $201K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 35,349 | $169K |
| 99217 | <1% | 431 | $161K | |
| 99218 | <1% | 443 | $158K | |
| 80053 | Comprehensive metabolic panel | <1% | 23,185 | $153K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,744 | $132K |
| 99221 | <1% | 366 | $126K | |
| 93017 | <1% | 872 | $126K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 160 | $123K |
| 36415 | Collection of venous blood by venipuncture | <1% | 55,917 | $123K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 76 | $120K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 388 | $119K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 108 | $119K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 330 | $118K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,304 | $118K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,322 | $116K |
| 84484 | <1% | 15,471 | $108K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,137 | $87K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,520 | $79K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,412 | $61K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12,598 | $56K |
| 80050 | General health panel | <1% | 338 | $50K |
| G0378 | Hospital observation service, per hour | <1% | 276 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,489 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,490 | $38K |
| 80061 | Lipid panel | <1% | 4,661 | $35K |
| 81001 | <1% | 16,125 | $31K | |
| 81025 | <1% | 4,765 | $30K | |
| 83690 | <1% | 8,435 | $30K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 116 | $28K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 203 | $27K |
| 87430 | <1% | 1,864 | $27K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 71 | $26K |
| 16020 | <1% | 158 | $21K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 755 | $18K |
| 83735 | <1% | 4,805 | $18K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 17 | $18K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 407 | $17K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 375 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 85 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,907 | $15K |
| 93246 | <1% | 55 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 210 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,515 | $14K |
| 85027 | <1% | 5,073 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,131 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 738 | $10K |
| 90870 | <1% | 275 | $10K | |
| 82947 | <1% | 5,096 | $9K | |
| 80076 | <1% | 2,653 | $9K | |
| 82077 | <1% | 670 | $8K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 283 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 412 | $7K |
| 87400 | <1% | 1,043 | $7K | |
| 83880 | <1% | 333 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 517 | $6K |
| 87807 | <1% | 464 | $6K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 28 | $5K |
| 93242 | <1% | 18 | $5K | |
| 84703 | <1% | 809 | $5K | |
| 80051 | <1% | 2,361 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 269 | $4K |
| 82565 | <1% | 2,364 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 166 | $3K |
| 84520 | <1% | 2,381 | $2K | |
| 87340 | <1% | 429 | $2K | |
| 81003 | <1% | 906 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 61 | $1K |
| 83605 | <1% | 210 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 230 | $1K |
| 85379 | <1% | 173 | $1K | |
| 85610 | <1% | 538 | $1K | |
| 86592 | <1% | 364 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 42 | $1K |
| 82248 | <1% | 285 | $963.85 | |
| 73630 | <1% | 37 | $792.78 | |
| 97161 | <1% | 21 | $745.84 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 85 | $660.03 |
| 82607 | <1% | 65 | $575.01 | |
| J3490 | Unclassified drugs | <1% | 28 | $474.18 |
| 87641 | <1% | 58 | $462.33 | |
| 82550 | <1% | 110 | $448.75 | |
| 87040 | <1% | 92 | $374.62 | |
| 84145 | <1% | 22 | $326.64 | |
| 84238 | <1% | 15 | $302.41 | |
| 88342 | <1% | 15 | $297.14 | |
| 82746 | <1% | 35 | $231.54 | |
| 84403 | <1% | 16 | $227.19 | |
| 82728 | <1% | 35 | $212.34 | |
| 85730 | <1% | 84 | $199.60 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,749 | $194.61 |
| 84439 | <1% | 44 | $193.85 | |
| 87077 | <1% | 33 | $185.84 | |
| 86803 | <1% | 16 | $165.27 | |
| 84702 | <1% | 16 | $159.76 | |
| 84100 | <1% | 53 | $137.46 | |
| 83550 | <1% | 34 | $127.73 | |
| 83540 | <1% | 34 | $94.58 | |
| 82043 | <1% | 43 | $85.35 | |
| 87210 | <1% | 31 | $84.60 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,810 | $80.59 |
| 96376 | <1% | 296 | $73.71 | |
| 81000 | <1% | 23 | $67.95 | |
| 84550 | <1% | 16 | $39.77 | |
| 86900 | <1% | 14 | $27.37 | |
| 86901 | <1% | 14 | $27.37 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 368 | $27.15 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 2,508 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 102 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 17 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 13 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 13 | $0.00 |
| 90715 | 0% | 16 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 379 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 152 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 242 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 263 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 66 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 361 | $0.00 |
| A9270 | Non-covered item or service | 0% | 96 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 12 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.